Mirjana Wollner
- Oncology top 5%
- Lung Cancer Research Studies 2
- HER2/EGFR in Cancer Research 1
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 2
-
- Lung Cancer Treatments and Mutations 2
-
- Radiomics and Machine Learning in Medical Imaging 1
- Medical Imaging Techniques and Applications 1
-
- Gastrointestinal Tumor Research and Treatment 1
-
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Alejandro NavarroParneet CheemaAlexander LuftM. Catherine PietanzaYiwen LuoGregory P. KalemkerianMark M. AwadCharles M. Rudin
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Thoracic Oncology (1 paper)JTO Clinical and Research Reports (1 paper)
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Mirjana Wollner
5 papers receiving 686 citations
Hit Papers
Peers
Comparison fields: 5 of 50
- Oncology 515
- Epidemiology 329
- Pulmonary and Respiratory Medicine 295
- Radiology, Nuclear Medicine and Imaging 149
- Molecular Biology 141
Countries citing papers authored by Mirjana Wollner
This map shows the geographic impact of Mirjana Wollner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjana Wollner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjana Wollner more than expected).
Fields of papers citing papers by Mirjana Wollner
This network shows the impact of papers produced by Mirjana Wollner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjana Wollner. The network helps show where Mirjana Wollner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mirjana Wollner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 34 | |
| 2 | 2023 | 3 | |
| 3 | Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Studybreakdown → | 2020 | 491 |
| 4 | Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma. | 2009 | 2 |
| 5 | PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. | 2004 | 166 |
About Mirjana Wollner
Mirjana Wollner is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 5 papers that have together received 696 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), HER2/EGFR in Cancer Research (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper), Medical Imaging Techniques and Applications (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Oncology (515 citations), Epidemiology (329 citations) and Pulmonary and Respiratory Medicine (295 citations). Mirjana Wollner has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Alejandro Navarro, Parneet Cheema, Alexander Luft, M. Catherine Pietanza, Yiwen Luo, Gregory P. Kalemkerian, Mark M. Awad, Charles M. Rudin, Delvys Rodríguez‐Abreu and Julien Mazières. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and JTO Clinical and Research Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.